Table of Content

Executive Summary
1. Global Ovarian Cancer Diagnostics Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-economic Factors
  1. Impact of Economic Growth and Healthcare Infrastructure on Diagnostic Access
  2. Trends in Public and Private Healthcare Spending on Cancer Screening and Diagnostics
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. PESTLE Analysis
5. Porter’s Five Force Analysis
Pricing and Reimbursement Analysis, 2024A
1. Key Highlights
2. Overview of Pricing Trends
3. Key Factors Influencing Testing Costs (e.g., Test Complexity, Equipment)
4. Reimbursement Landscape by Region
5. Impact of Testing Factors (e.g., Specimen Type, Turnaround Time) on Cost
Global Ovarian Cancer Diagnostics Market Outlook
1. Key Highlights
  1. Market Volume (Units) Projections
  2. Market Size (US$ Mn) and Y-o-Y Growth
  3. Absolute $ Opportunity
2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  2. Current Market Size (US$ Mn) Analysis and Forecast, 2025 - 2032
3. Global Ovarian Cancer Diagnostics Market Outlook: Cancer Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Cancer Type, 2019 - 2024
  3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Cancer Type, 2025 - 2032
    1. Epithelial Tumor
    2. Germ Cell Tumor
    3. Stromal Cell Tumor
    4. Others
  4. Market Attractiveness Analysis: Cancer Type
4. Global Ovarian Cancer Diagnostics Market Outlook: Diagnosis
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Diagnosis, 2019 - 2024
  3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnosis, 2025 - 2032
    1. Imaging
      1. Ultrasound
      2. CT Scan
      3. MRI Scan
      4. PET Scan
      5. Others
    2. Blood Test
      1. CA125
      2. HER2
      3. BRCA
      4. CEA
      5. ER and PR
      6. KRAS Mutation
      7. Others
    3. Biopsy
    4. Others
  4. Market Attractiveness Analysis: Diagnosis
5. Global Ovarian Cancer Diagnostics Market Outlook: End Use
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By End Use, 2019 - 2024
  3. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
    1. Hospital Laboratories
    2. Cancer Diagnostic Centers
    3. Research Institutes
    4. Others
  4. Market Attractiveness Analysis: End Use
Global Ovarian Cancer Diagnostics Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019 - 2024
3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Ovarian Cancer Diagnostics Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Cancer Type
  3. By Diagnosis
  4. By End Use
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. U.S.
  2. Canada
4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Cancer Type, 2025 - 2032
  1. Epithelial Tumor
  2. Germ Cell Tumor
  3. Stromal Cell Tumor
  4. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnosis, 2025 - 2032
  1. 1. Imaging
      1. Ultrasound
      2. CT Scan
      3. MRI Scan
      4. PET Scan
      5. Others
    2. Blood Test
      1. CA125
      2. HER2
      3. BRCA
      4. CEA
      5. ER and PR
      6. KRAS Mutation
      7. Others
    3. Biopsy
  2. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
  1. Hospitals
  2. Clinical Laboratories
  3. Others
7. Market Attractiveness Analysis
Europe Ovarian Cancer Diagnostics Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Cancer Type
  3. By Diagnosis
  4. By End Use
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Cancer Type, 2025 - 2032
  1. Epithelial Tumor
  2. Germ Cell Tumor
  3. Stromal Cell Tumor
  4. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnosis, 2025 - 2032
  1. 1. Imaging
      1. Ultrasound
      2. CT Scan
      3. MRI Scan
      4. PET Scan
      5. Others
    2. Blood Test
      1. CA125
      2. HER2
      3. BRCA
      4. CEA
      5. ER and PR
      6. KRAS Mutation
      7. Others
    3. Biopsy
  2. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
  1. Hospitals
  2. Clinical Laboratories
  3. Others
7. Market Attractiveness Analysis
East Asia Ovarian Cancer Diagnostics Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Cancer Type
  3. By Diagnosis
  4. By End Use
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. China
  2. Japan
  3. South Korea
4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Cancer Type, 2025 - 2032
  1. Epithelial Tumor
  2. Germ Cell Tumor
  3. Stromal Cell Tumor
  4. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnosis, 2025 - 2032
  1. 1. Imaging
      1. Ultrasound
      2. CT Scan
      3. MRI Scan
      4. PET Scan
      5. Others
    2. Blood Test
      1. CA125
      2. HER2
      3. BRCA
      4. CEA
      5. ER and PR
      6. KRAS Mutation
      7. Others
    3. Biopsy
  2. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
  1. Hospitals
  2. Clinical Laboratories
  3. Others
7. Market Attractiveness Analysis
South Asia & Oceania Ovarian Cancer Diagnostics Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Cancer Type
  3. By Diagnosis
  4. By End Use
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Cancer Type, 2025 - 2032
  1. Epithelial Tumor
  2. Germ Cell Tumor
  3. Stromal Cell Tumor
  4. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnosis, 2025 - 2032
  1. 1. Imaging
      1. Ultrasound
      2. CT Scan
      3. MRI Scan
      4. PET Scan
      5. Others
    2. Blood Test
      1. CA125
      2. HER2
      3. BRCA
      4. CEA
      5. ER and PR
      6. KRAS Mutation
      7. Others
    3. Biopsy
  2. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
  1. Hospitals
  2. Clinical Laboratories
  3. Others
7. Market Attractiveness Analysis
Latin America Ovarian Cancer Diagnostics Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Cancer Type
  3. By Diagnosis
  4. By End Use
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Cancer Type, 2025 - 2032
  1. Epithelial Tumor
  2. Germ Cell Tumor
  3. Stromal Cell Tumor
  4. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnosis, 2025 - 2032
  1. 1. Imaging
      1. Ultrasound
      2. CT Scan
      3. MRI Scan
      4. PET Scan
      5. Others
    2. Blood Test
      1. CA125
      2. HER2
      3. BRCA
      4. CEA
      5. ER and PR
      6. KRAS Mutation
      7. Others
    3. Biopsy
  2. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
  1. Hospitals
  2. Clinical Laboratories
  3. Others
7. Market Attractiveness Analysis
Middle East & Africa Ovarian Cancer Diagnostics Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Cancer Type
  3. By Diagnosis
  4. By End Use
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Cancer Type, 2025 - 2032
  1. Epithelial Tumor
  2. Germ Cell Tumor
  3. Stromal Cell Tumor
  4. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnosis, 2025 - 2032
  1. 1. Imaging
      1. Ultrasound
      2. CT Scan
      3. MRI Scan
      4. PET Scan
      5. Others
    2. Blood Test
      1. CA125
      2. HER2
      3. BRCA
      4. CEA
      5. ER and PR
      6. KRAS Mutation
      7. Others
    3. Biopsy
  2. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
  1. Hospitals
  2. Clinical Laboratories
  3. Others
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. F. Hoffmann-La Roche AG
    1. Overview
    2. Segments and Cancer Types
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. AstraZeneca Plc
  3. Johnson & Johnson Services Inc.
  4. GlaxoSmithKline Plc
  5. Bio-Rad Laboratories, Inc.
  6. Siemens Healthcare GmbH
  7. Thermo Fisher Scientific
  8. Abbott Laboratories
  9. Illumina, Inc.
  10. Quest Diagnostics Incorporated
  11. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Our Media Trust

Testimonials

“Persistence Market Research has helped us immensely in compiling a sound database. Our expectations were exceeded by their research team.”

Fortune 500 Telecom Company, USA

“The market numbers supplied by Persistence Market Research helped us successfully conclude our ongoing project and we are pleased with this purchase.”

Multinational Chemical Company, USA

“The customer service provided by Persistence Market Research was great. We got our report well in time and customized to suit our business requirements.”

Multinational Electronics Company, Japan

“The way Persistence Market Research handled the entire transaction, right from Customisation to after-sales queries, has been very impressive.”

Leading Semiconductors Company, Taiwan

“Thank you for supplying the report in time for our project to go through. Commendable customer service.”

Leading Global Healthcare Fortune 500 Company, USA

“The precise information given in Persistence Market Research’s reports has been priceless to us. We are very happy with this purchase, since the analysis in the report has been important in formulating our strategies.”

Global Consulting Firm, USA

Research Methodology

Data-Driven Research Methodology for Accurate Insights

Customisation

Tailor-made research to suit your business growth

Ovarian Cancer Diagnostics Market Size, Share, and Growth Forecast for 2025 - 2032

Ovarian Cancer Diagnostics Market by Cancer Type (Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor), by Diagnosis (Imaging, Blood Test, Biopsy), by End Use (Hospital Laboratories, Cancer Diagnostic Centers), and Regional Analysis for 2025 - 2032

Table of Content